お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、mRNAワクチンコア酵素の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にmRNAワクチンコア酵素市場を分類しています。
本レポートでは世界のmRNAワクチンコア酵素市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Thermo Fisher、NEB、TriLink Bio Technologies、Merck、Aldevron、Qiagen N.V.、Promega、Roche CustomBiotech、Takara Bio Inc.、Novoprotein、Vazyme、Hongene Biotech Corporatio、Yeasen Biotechnology

レポートはmRNAワクチンコア酵素の主要生産者を調査し、主要地域や国の消費状況も提供します。mRNAワクチンコア酵素の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Capping Enzyme
    2'-O-Methyltransferase
    Inorganic Pyrophosphatase
    Poly (A) Polymerase
    Rnase Inhibitor
    RNA Polymerase
    Restriction Enzyme
    Dnase I
    Others

用途別の市場セグメント：
    Biopharmaceutical Companies
    Academic and Research Institutions

本レポートの詳細内容
本レポートは、世界のmRNAワクチンコア酵素市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてmRNAワクチンコア酵素市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）のmRNAワクチンコア酵素生産量、成長率、市場シェアを調査している。

二. 消費面では、mRNAワクチンコア酵素の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのmRNAワクチンコア酵素売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のmRNAワクチンコア酵素市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本mRNAワクチンコア酵素のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：mRNAワクチンコア酵素のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： mRNAワクチンコア酵素の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおけるmRNAワクチンコア酵素の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章mRNAワクチンコア酵素メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：mRNAワクチンコア酵素の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：mRNAワクチンコア酵素の主要メーカーの概要を提供し、製品の説明と仕様、mRNAワクチンコア酵素の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：mRNAワクチンコア酵素の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development. mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs.
The global mRNA Vaccine Core Enzyme market is projected to grow from US$ 2008 million in 2024 to US$ 1726 million by 2030, at a Compound Annual Growth Rate (CAGR) of -2.5% during the forecast period.
The core manufacturers of mRNA Vaccine Core Enzyme mainly include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, etc. The top four companies in the industry account for about 49% of the market. North America is the largest market, accounting for about 38% of the global market share. In terms of product type, Capping Enzyme have the largest market share of about 25%. From an application perspective, Biopharmaceutical Companies account for the largest share at around 84%.
Report Includes
This report presents an overview of global market for mRNA Vaccine Core Enzyme, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of mRNA Vaccine Core Enzyme, also provides the sales of main regions and countries. Highlights of the upcoming market potential for mRNA Vaccine Core Enzyme, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the mRNA Vaccine Core Enzyme sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global mRNA Vaccine Core Enzyme market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Enzyme Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for mRNA Vaccine Core Enzyme sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, Qiagen N.V., Promega, Roche CustomBiotech, Takara Bio Inc., Novoprotein, etc.
Market Segmentation
By Company
    Thermo Fisher
    NEB
    TriLink Bio Technologies
    Merck
    Aldevron
    Qiagen N.V.
    Promega
    Roche CustomBiotech
    Takara Bio Inc.
    Novoprotein
    Vazyme
    Hongene Biotech Corporatio
    Yeasen Biotechnology

Segment by Enzyme Type
    Capping Enzyme
    2'-O-Methyltransferase
    Inorganic Pyrophosphatase
    Poly (A) Polymerase
    Rnase Inhibitor
    RNA Polymerase
    Restriction Enzyme
    Dnase I
    Others

Segment by Application
    Biopharmaceutical Companies
    Academic and Research Institutions

Segment by region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Enzyme Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of mRNA Vaccine Core Enzyme in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of mRNA Vaccine Core Enzyme manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Enzyme Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Enzyme Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Enzyme Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Enzyme Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Enzyme Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Enzyme Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Vaccine Core Enzyme sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
 Table 1. Global mRNA Vaccine Core Enzyme Market Size Growth Rate by Enzyme Type, 2019 VS 2023 VS 2030 (US$ Million)
 Table 2. Major Manufacturers of Capping Enzyme
 Table 3. Major Manufacturers of 2'-O-Methyltransferase
 Table 4. Major Manufacturers of Inorganic Pyrophosphatase
 Table 5. Major Manufacturers of Poly (A) Polymerase
 Table 6. Major Manufacturers of Rnase Inhibitor
 Table 7. Major Manufacturers of RNA Polymerase
 Table 8. Major Manufacturers of Restriction Enzyme
 Table 9. Major Manufacturers of Dnase I
 Table 10. Major Manufacturers of Others
 Table 11. Global mRNA Vaccine Core Enzyme Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Table 12. Global mRNA Vaccine Core Enzyme Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 13. Global mRNA Vaccine Core Enzyme Revenue by Region (2019-2024) & (US$ Million)
 Table 14. Global mRNA Vaccine Core Enzyme Revenue by Region (2025-2030) & (US$ Million)
 Table 15. Global mRNA Vaccine Core Enzyme Revenue Market Share by Region (2019-2024)
 Table 16. Global mRNA Vaccine Core Enzyme Revenue Market Share by Region (2025-2030)
 Table 17. Global mRNA Vaccine Core Enzyme Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Table 18. Global mRNA Vaccine Core Enzyme Sales by Region (2019-2024) & (K Units)
 Table 19. Global mRNA Vaccine Core Enzyme Sales by Region (2025-2030) & (K Units)
 Table 20. Global mRNA Vaccine Core Enzyme Sales Market Share by Region (2019-2024)
 Table 21. Global mRNA Vaccine Core Enzyme Sales Market Share by Region (2025-2030)
 Table 22. Global mRNA Vaccine Core Enzyme Sales by Manufacturers (2019-2024) & (K Units)
 Table 23. Global mRNA Vaccine Core Enzyme Sales Share by Manufacturers (2019-2024)
 Table 24. Global mRNA Vaccine Core Enzyme Revenue by Manufacturers (2019-2024) & (US$ Million)
 Table 25. Global mRNA Vaccine Core Enzyme Revenue Market Share by Manufacturers (2019-2024)
 Table 26. Global Key Players of mRNA Vaccine Core Enzyme, Industry Ranking, 2021 VS 2022 VS 2023
 Table 27. mRNA Vaccine Core Enzyme Price by Manufacturers (2019-2024) & (US$/Unit)
 Table 28. Global mRNA Vaccine Core Enzyme Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 29. Global mRNA Vaccine Core Enzyme by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine Core Enzyme as of 2023)
 Table 30. Global Key Manufacturers of mRNA Vaccine Core Enzyme, Manufacturing Base Distribution and Headquarters
 Table 31. Global Key Manufacturers of mRNA Vaccine Core Enzyme, Product Offered and Application
 Table 32. Global Key Manufacturers of mRNA Vaccine Core Enzyme, Date of Enter into This Industry
 Table 33. Mergers & Acquisitions, Expansion Plans
 Table 34. Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2019-2024) & (K Units)
 Table 35. Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2025-2030) & (K Units)
 Table 36. Global mRNA Vaccine Core Enzyme Sales Share by Enzyme Type (2019-2024)
 Table 37. Global mRNA Vaccine Core Enzyme Sales Share by Enzyme Type (2025-2030)
 Table 38. Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2019-2024) & (US$ Million)
 Table 39. Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2025-2030) & (US$ Million)
 Table 40. Global mRNA Vaccine Core Enzyme Revenue Share by Enzyme Type (2019-2024)
 Table 41. Global mRNA Vaccine Core Enzyme Revenue Share by Enzyme Type (2025-2030)
 Table 42. mRNA Vaccine Core Enzyme Price by Enzyme Type (2019-2024) & (US$/Unit)
 Table 43. Global mRNA Vaccine Core Enzyme Price Forecast by Enzyme Type (2025-2030) & (US$/Unit)
 Table 44. Global mRNA Vaccine Core Enzyme Sales by Application (2019-2024) & (K Units)
 Table 45. Global mRNA Vaccine Core Enzyme Sales by Application (2025-2030) & (K Units)
 Table 46. Global mRNA Vaccine Core Enzyme Sales Share by Application (2019-2024)
 Table 47. Global mRNA Vaccine Core Enzyme Sales Share by Application (2025-2030)
 Table 48. Global mRNA Vaccine Core Enzyme Revenue by Application (2019-2024) & (US$ Million)
 Table 49. Global mRNA Vaccine Core Enzyme Revenue by Application (2025-2030) & (US$ Million)
 Table 50. Global mRNA Vaccine Core Enzyme Revenue Share by Application (2019-2024)
 Table 51. Global mRNA Vaccine Core Enzyme Revenue Share by Application (2025-2030)
 Table 52. mRNA Vaccine Core Enzyme Price by Application (2019-2024) & (US$/Unit)
 Table 53. Global mRNA Vaccine Core Enzyme Price Forecast by Application (2025-2030) & (US$/Unit)
 Table 54. US & Canada mRNA Vaccine Core Enzyme Sales by Enzyme Type (2019-2024) & (K Units)
 Table 55. US & Canada mRNA Vaccine Core Enzyme Sales by Enzyme Type (2025-2030) & (K Units)
 Table 56. US & Canada mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2019-2024) & (US$ Million)
 Table 57. US & Canada mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2025-2030) & (US$ Million)
 Table 58. US & Canada mRNA Vaccine Core Enzyme Sales by Application (2019-2024) & (K Units)
 Table 59. US & Canada mRNA Vaccine Core Enzyme Sales by Application (2025-2030) & (K Units)
 Table 60. US & Canada mRNA Vaccine Core Enzyme Revenue by Application (2019-2024) & (US$ Million)
 Table 61. US & Canada mRNA Vaccine Core Enzyme Revenue by Application (2025-2030) & (US$ Million)
 Table 62. US & Canada mRNA Vaccine Core Enzyme Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 63. US & Canada mRNA Vaccine Core Enzyme Revenue by Country (2019-2024) & (US$ Million)
 Table 64. US & Canada mRNA Vaccine Core Enzyme Revenue by Country (2025-2030) & (US$ Million)
 Table 65. US & Canada mRNA Vaccine Core Enzyme Sales by Country (2019-2024) & (K Units)
 Table 66. US & Canada mRNA Vaccine Core Enzyme Sales by Country (2025-2030) & (K Units)
 Table 67. Europe mRNA Vaccine Core Enzyme Sales by Enzyme Type (2019-2024) & (K Units)
 Table 68. Europe mRNA Vaccine Core Enzyme Sales by Enzyme Type (2025-2030) & (K Units)
 Table 69. Europe mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2019-2024) & (US$ Million)
 Table 70. Europe mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2025-2030) & (US$ Million)
 Table 71. Europe mRNA Vaccine Core Enzyme Sales by Application (2019-2024) & (K Units)
 Table 72. Europe mRNA Vaccine Core Enzyme Sales by Application (2025-2030) & (K Units)
 Table 73. Europe mRNA Vaccine Core Enzyme Revenue by Application (2019-2024) & (US$ Million)
 Table 74. Europe mRNA Vaccine Core Enzyme Revenue by Application (2025-2030) & (US$ Million)
 Table 75. Europe mRNA Vaccine Core Enzyme Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 76. Europe mRNA Vaccine Core Enzyme Revenue by Country (2019-2024) & (US$ Million)
 Table 77. Europe mRNA Vaccine Core Enzyme Revenue by Country (2025-2030) & (US$ Million)
 Table 78. Europe mRNA Vaccine Core Enzyme Sales by Country (2019-2024) & (K Units)
 Table 79. Europe mRNA Vaccine Core Enzyme Sales by Country (2025-2030) & (K Units)
 Table 80. China mRNA Vaccine Core Enzyme Sales by Enzyme Type (2019-2024) & (K Units)
 Table 81. China mRNA Vaccine Core Enzyme Sales by Enzyme Type (2025-2030) & (K Units)
 Table 82. China mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2019-2024) & (US$ Million)
 Table 83. China mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2025-2030) & (US$ Million)
 Table 84. China mRNA Vaccine Core Enzyme Sales by Application (2019-2024) & (K Units)
 Table 85. China mRNA Vaccine Core Enzyme Sales by Application (2025-2030) & (K Units)
 Table 86. China mRNA Vaccine Core Enzyme Revenue by Application (2019-2024) & (US$ Million)
 Table 87. China mRNA Vaccine Core Enzyme Revenue by Application (2025-2030) & (US$ Million)
 Table 88. Asia mRNA Vaccine Core Enzyme Sales by Enzyme Type (2019-2024) & (K Units)
 Table 89. Asia mRNA Vaccine Core Enzyme Sales by Enzyme Type (2025-2030) & (K Units)
 Table 90. Asia mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2019-2024) & (US$ Million)
 Table 91. Asia mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2025-2030) & (US$ Million)
 Table 92. Asia mRNA Vaccine Core Enzyme Sales by Application (2019-2024) & (K Units)
 Table 93. Asia mRNA Vaccine Core Enzyme Sales by Application (2025-2030) & (K Units)
 Table 94. Asia mRNA Vaccine Core Enzyme Revenue by Application (2019-2024) & (US$ Million)
 Table 95. Asia mRNA Vaccine Core Enzyme Revenue by Application (2025-2030) & (US$ Million)
 Table 96. Asia mRNA Vaccine Core Enzyme Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 97. Asia mRNA Vaccine Core Enzyme Revenue by Region (2019-2024) & (US$ Million)
 Table 98. Asia mRNA Vaccine Core Enzyme Revenue by Region (2025-2030) & (US$ Million)
 Table 99. Asia mRNA Vaccine Core Enzyme Sales by Region (2019-2024) & (K Units)
 Table 100. Asia mRNA Vaccine Core Enzyme Sales by Region (2025-2030) & (K Units)
 Table 101. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Sales by Enzyme Type (2019-2024) & (K Units)
 Table 102. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Sales by Enzyme Type (2025-2030) & (K Units)
 Table 103. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2019-2024) & (US$ Million)
 Table 104. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2025-2030) & (US$ Million)
 Table 105. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Sales by Application (2019-2024) & (K Units)
 Table 106. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Sales by Application (2025-2030) & (K Units)
 Table 107. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Revenue by Application (2019-2024) & (US$ Million)
 Table 108. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Revenue by Application (2025-2030) & (US$ Million)
 Table 109. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 110. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Revenue by Country (2019-2024) & (US$ Million)
 Table 111. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Revenue by Country (2025-2030) & (US$ Million)
 Table 112. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Sales by Country (2019-2024) & (K Units)
 Table 113. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Sales by Country (2025-2030) & (K Units)
 Table 114. Thermo Fisher Company Information
 Table 115. Thermo Fisher Description and Major Businesses
 Table 116. Thermo Fisher mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 117. Thermo Fisher mRNA Vaccine Core Enzyme Product Model Numbers, Pictures, Descriptions and Specifications
 Table 118. Thermo Fisher Recent Developments
 Table 119. NEB Company Information
 Table 120. NEB Description and Major Businesses
 Table 121. NEB mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 122. NEB mRNA Vaccine Core Enzyme Product Model Numbers, Pictures, Descriptions and Specifications
 Table 123. NEB Recent Developments
 Table 124. TriLink Bio Technologies Company Information
 Table 125. TriLink Bio Technologies Description and Major Businesses
 Table 126. TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 127. TriLink Bio Technologies mRNA Vaccine Core Enzyme Product Model Numbers, Pictures, Descriptions and Specifications
 Table 128. TriLink Bio Technologies Recent Developments
 Table 129. Merck Company Information
 Table 130. Merck Description and Major Businesses
 Table 131. Merck mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 132. Merck mRNA Vaccine Core Enzyme Product Model Numbers, Pictures, Descriptions and Specifications
 Table 133. Merck Recent Developments
 Table 134. Aldevron Company Information
 Table 135. Aldevron Description and Major Businesses
 Table 136. Aldevron mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 137. Aldevron mRNA Vaccine Core Enzyme Product Model Numbers, Pictures, Descriptions and Specifications
 Table 138. Aldevron Recent Developments
 Table 139. Qiagen N.V. Company Information
 Table 140. Qiagen N.V. Description and Major Businesses
 Table 141. Qiagen N.V. mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 142. Qiagen N.V. mRNA Vaccine Core Enzyme Product Model Numbers, Pictures, Descriptions and Specifications
 Table 143. Qiagen N.V. Recent Developments
 Table 144. Promega Company Information
 Table 145. Promega Description and Major Businesses
 Table 146. Promega mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 147. Promega mRNA Vaccine Core Enzyme Product Model Numbers, Pictures, Descriptions and Specifications
 Table 148. Promega Recent Developments
 Table 149. Roche CustomBiotech Company Information
 Table 150. Roche CustomBiotech Description and Major Businesses
 Table 151. Roche CustomBiotech mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 152. Roche CustomBiotech mRNA Vaccine Core Enzyme Product Model Numbers, Pictures, Descriptions and Specifications
 Table 153. Roche CustomBiotech Recent Developments
 Table 154. Takara Bio Inc. Company Information
 Table 155. Takara Bio Inc. Description and Major Businesses
 Table 156. Takara Bio Inc. mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 157. Takara Bio Inc. mRNA Vaccine Core Enzyme Product Model Numbers, Pictures, Descriptions and Specifications
 Table 158. Takara Bio Inc. Recent Developments
 Table 159. Novoprotein Company Information
 Table 160. Novoprotein Description and Major Businesses
 Table 161. Novoprotein mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 162. Novoprotein mRNA Vaccine Core Enzyme Product Model Numbers, Pictures, Descriptions and Specifications
 Table 163. Novoprotein Recent Developments
 Table 164. Vazyme Company Information
 Table 165. Vazyme Description and Major Businesses
 Table 166. Vazyme mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 167. Vazyme mRNA Vaccine Core Enzyme Product Model Numbers, Pictures, Descriptions and Specifications
 Table 168. Vazyme Recent Developments
 Table 169. Hongene Biotech Corporatio Company Information
 Table 170. Hongene Biotech Corporatio Description and Major Businesses
 Table 171. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 172. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product Model Numbers, Pictures, Descriptions and Specifications
 Table 173. Hongene Biotech Corporatio Recent Developments
 Table 174. Yeasen Biotechnology Company Information
 Table 175. Yeasen Biotechnology Description and Major Businesses
 Table 176. Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 177. Yeasen Biotechnology mRNA Vaccine Core Enzyme Product Model Numbers, Pictures, Descriptions and Specifications
 Table 178. Yeasen Biotechnology Recent Developments
 Table 179. Key Raw Materials Lists
 Table 180. Raw Materials Key Suppliers Lists
 Table 181. mRNA Vaccine Core Enzyme Distributors List
 Table 182. mRNA Vaccine Core Enzyme Customers List
 Table 183. mRNA Vaccine Core Enzyme Market Trends
 Table 184. mRNA Vaccine Core Enzyme Market Drivers
 Table 185. mRNA Vaccine Core Enzyme Market Challenges
 Table 186. mRNA Vaccine Core Enzyme Market Restraints
 Table 187. Research Programs/Design for This Report
 Table 188. Key Data Information from Secondary Sources
 Table 189. Key Data Information from Primary Sources


List of Figures
 Figure 1. mRNA Vaccine Core Enzyme Product Picture
 Figure 2. Global mRNA Vaccine Core Enzyme Market Size Growth Rate by Enzyme Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global mRNA Vaccine Core Enzyme Market Share by Enzyme Type: 2023 & 2030
 Figure 4. Capping Enzyme Product Picture
 Figure 5. 2'-O-Methyltransferase Product Picture
 Figure 6. Inorganic Pyrophosphatase Product Picture
 Figure 7. Poly (A) Polymerase Product Picture
 Figure 8. Rnase Inhibitor Product Picture
 Figure 9. RNA Polymerase Product Picture
 Figure 10. Restriction Enzyme Product Picture
 Figure 11. Dnase I Product Picture
 Figure 12. Others Product Picture
 Figure 13. Global mRNA Vaccine Core Enzyme Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 14. Global mRNA Vaccine Core Enzyme Market Share by Application: 2023 & 2030
 Figure 15. Biopharmaceutical Companies
 Figure 16. Academic and Research Institutions
 Figure 17. mRNA Vaccine Core Enzyme Report Years Considered
 Figure 18. Global mRNA Vaccine Core Enzyme Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 19. Global mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 20. Global mRNA Vaccine Core Enzyme Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 21. Global mRNA Vaccine Core Enzyme Revenue Market Share by Region in Percentage: 2023 Versus 2030
 Figure 22. Global mRNA Vaccine Core Enzyme Revenue Market Share by Region (2019-2030)
 Figure 23. Global mRNA Vaccine Core Enzyme Sales (2019-2030) & (K Units)
 Figure 24. Global mRNA Vaccine Core Enzyme Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Figure 25. Global mRNA Vaccine Core Enzyme Sales Market Share by Region (2019-2030)
 Figure 26. US & Canada mRNA Vaccine Core Enzyme Sales YoY (2019-2030) & (K Units)
 Figure 27. US & Canada mRNA Vaccine Core Enzyme Revenue YoY (2019-2030) & (US$ Million)
 Figure 28. Europe mRNA Vaccine Core Enzyme Sales YoY (2019-2030) & (K Units)
 Figure 29. Europe mRNA Vaccine Core Enzyme Revenue YoY (2019-2030) & (US$ Million)
 Figure 30. China mRNA Vaccine Core Enzyme Sales YoY (2019-2030) & (K Units)
 Figure 31. China mRNA Vaccine Core Enzyme Revenue YoY (2019-2030) & (US$ Million)
 Figure 32. Asia (excluding China) mRNA Vaccine Core Enzyme Sales YoY (2019-2030) & (K Units)
 Figure 33. Asia (excluding China) mRNA Vaccine Core Enzyme Revenue YoY (2019-2030) & (US$ Million)
 Figure 34. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Sales YoY (2019-2030) & (K Units)
 Figure 35. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Revenue YoY (2019-2030) & (US$ Million)
 Figure 36. Global mRNA Vaccine Core Enzyme Sales Share by Manufacturers (2023)
 Figure 37. The mRNA Vaccine Core Enzyme Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
 Figure 38. Global mRNA Vaccine Core Enzyme Revenue Share by Manufacturers (2023)
 Figure 39. The Top 5 and 10 Largest Manufacturers of mRNA Vaccine Core Enzyme in the World: Market Share by mRNA Vaccine Core Enzyme Revenue in 2023
 Figure 40. Global mRNA Vaccine Core Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 41. Global mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2019-2030)
 Figure 42. Global mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2019-2030)
 Figure 43. Global mRNA Vaccine Core Enzyme Sales Market Share by Application (2019-2030)
 Figure 44. Global mRNA Vaccine Core Enzyme Revenue Market Share by Application (2019-2030)
 Figure 45. US & Canada mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2019-2030)
 Figure 46. US & Canada mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2019-2030)
 Figure 47. US & Canada mRNA Vaccine Core Enzyme Sales Market Share by Application (2019-2030)
 Figure 48. US & Canada mRNA Vaccine Core Enzyme Revenue Market Share by Application (2019-2030)
 Figure 49. US & Canada mRNA Vaccine Core Enzyme Revenue Share by Country (2019-2030)
 Figure 50. US & Canada mRNA Vaccine Core Enzyme Sales Share by Country (2019-2030)
 Figure 51. US mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 52. Canada mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 53. Europe mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2019-2030)
 Figure 54. Europe mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2019-2030)
 Figure 55. Europe mRNA Vaccine Core Enzyme Sales Market Share by Application (2019-2030)
 Figure 56. Europe mRNA Vaccine Core Enzyme Revenue Market Share by Application (2019-2030)
 Figure 57. Europe mRNA Vaccine Core Enzyme Revenue Share by Country (2019-2030)
 Figure 58. Europe mRNA Vaccine Core Enzyme Sales Share by Country (2019-2030)
 Figure 59. Germany mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 60. France mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 61. U.K. mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 62. Italy mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 63. Russia mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 64. China mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2019-2030)
 Figure 65. China mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2019-2030)
 Figure 66. China mRNA Vaccine Core Enzyme Sales Market Share by Application (2019-2030)
 Figure 67. China mRNA Vaccine Core Enzyme Revenue Market Share by Application (2019-2030)
 Figure 68. Asia mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2019-2030)
 Figure 69. Asia mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2019-2030)
 Figure 70. Asia mRNA Vaccine Core Enzyme Sales Market Share by Application (2019-2030)
 Figure 71. Asia mRNA Vaccine Core Enzyme Revenue Market Share by Application (2019-2030)
 Figure 72. Asia mRNA Vaccine Core Enzyme Revenue Share by Region (2019-2030)
 Figure 73. Asia mRNA Vaccine Core Enzyme Sales Share by Region (2019-2030)
 Figure 74. Japan mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 75. South Korea mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 76. China Taiwan mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 77. Southeast Asia mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 78. India mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 79. Australia mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 80. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2019-2030)
 Figure 81. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2019-2030)
 Figure 82. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Sales Market Share by Application (2019-2030)
 Figure 83. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Revenue Market Share by Application (2019-2030)
 Figure 84. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Revenue Share by Country (2019-2030)
 Figure 85. Middle East, Africa and Latin America mRNA Vaccine Core Enzyme Sales Share by Country (2019-2030)
 Figure 86. Brazil mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 87. Mexico mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 88. Turkey mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 89. Israel mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 90. GCC Countries mRNA Vaccine Core Enzyme Revenue (2019-2030) & (US$ Million)
 Figure 91. mRNA Vaccine Core Enzyme Value Chain
 Figure 92. mRNA Vaccine Core Enzyme Production Process
 Figure 93. Channels of Distribution (Direct Vs Distribution)
 Figure 94. Bottom-up and Top-down Approaches for This Report
 Figure 95. Data Triangulation
 Figure 96. Key Executives Interviewed